Benzodiazepine hypnotics bear a higher risk of high dose dependence than benzodiazepine anxiolytics, according to a recent study in Luxemburg. This article summarizes the main indications of these molecules and the current treatment recommendations. It provides an overview of public health actions of the past and the future to reduce their excessive consumption.
|Translated title of the contribution||In process|
|Number of pages||13|
|Journal||Bulletin de la Société des Sciences Médicales du Grand-Duché de Luxembourg|
|Publication status||Published - 1 Jan 2016|